v3.24.2
Condensed Consolidated Statement of Stockholders' (Deficit)/Equity (Q1) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2021     $ 100 $ (59,096,500) $ (59,096,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Profit/(Loss)     0 50,523,700 $ 50,523,700
Stock Based Compensation (in shares)         0
Ending balance at Dec. 31, 2022 $ 8,800 $ 0 0 (8,581,300) $ (8,572,500)
Balance at the end (in shares) at Dec. 31, 2022 87,500,000 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Profit/(Loss) $ 0 $ 0 0 (210,300) (210,300)
Conversion of convertible notes into common stock upon Business Combination         0
Ending balance at Mar. 31, 2023 $ 8,800 $ 0 0 (8,791,600) (8,782,800)
Balance at the end (in shares) at Mar. 31, 2023 87,500,000 0      
Beginning balance at Dec. 31, 2022 $ 8,800 $ 0 0 (8,581,300) (8,572,500)
Balance at the beginning (in shares) at Dec. 31, 2022 87,500,000 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Profit/(Loss)     0 (58,189,200) $ (58,189,200)
Stock Based Compensation (in shares)         0
Ending balance at Dec. 31, 2023 $ 8,800 $ 0 0 (66,770,700) $ (66,761,900)
Balance at the end (in shares) at Dec. 31, 2023 87,500,000 0      
Beginning balance at Mar. 31, 2023 $ 8,800 $ 0 0 (8,791,600) (8,782,800)
Balance at the beginning (in shares) at Mar. 31, 2023 87,500,000 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Profit/(Loss) $ 0 $ 0 0 (22,768,100) (22,768,100)
Ending balance at Jun. 30, 2023 $ 8,800 $ 0 0 (31,559,700) (31,550,900)
Balance at the end (in shares) at Jun. 30, 2023 87,500,000 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Profit/(Loss) $ 0 $ 0 0 (26,033,100) (26,033,100)
Ending balance at Sep. 30, 2023 $ 8,800 $ 0 0 (57,592,800) (57,584,000)
Balance at the end (in shares) at Sep. 30, 2023 87,500,000 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Profit/(Loss) $ 0 $ 0 0 (9,177,900) (9,177,900)
Ending balance at Dec. 31, 2023 $ 8,800 $ 0 0 (66,770,700) (66,761,900)
Balance at the end (in shares) at Dec. 31, 2023 87,500,000 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Profit/(Loss) $ 0 $ 0 0 (327,599,700) (327,599,700)
Fair value of TMTG earnout shares     2,477,550,200 (2,477,550,200) 0
Conversion of convertible notes into common stock upon Business Combination $ 600 $ 0 300,425,400 0 300,426,000
Convertible notes issued (in shares) 6,014,534 0      
Stock Based Compensation $ 200 $ 0 84,587,800   84,588,000
Stock Based Compensation (in shares) 1,840,000 0      
Issuance of common stock upon Business Combination $ 4,100 $ 0 219,617,500   $ 219,621,600
Issuance of common stock upon Business Combination (in shares) 41,346,049 0     87,500,000 [1]
Ending balance at Mar. 31, 2024 $ 13,700 $ 0 $ 3,082,180,900 $ (2,871,920,600) $ 210,274,000
Balance at the end (in shares) at Mar. 31, 2024 136,700,583 0      
[1] Includes 614,640 shares outstanding and held in escrow